Zanger U M, Fischer J, Raimundo S, Stüven T, Evert B O, Schwab M, Eichelbaum M
Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
Pharmacogenetics. 2001 Oct;11(7):573-85. doi: 10.1097/00008571-200110000-00004.
Variable expression and function of the cytochrome P4502D6 (CYP2D6) leads to distinct phenotypes termed ultrarapid (UM), extensive (EM), intermediate (IM) and poor metabolizer (PM). Whereas the PM phenotype is known to be caused by two null-alleles leading to absence of functional CYP2D6 protein, the large variability among individuals with functional alleles remained largely unexplained. In this study, we systematically investigated 76 liver biopsies from individuals with known sparteine metabolic ratios (MRS) for the relationships between CYP2D6 genotype, microsomal protein expression, bufuralol 1'-hydroxylase activity and in-vivo phenotype. Average CYP2D6 protein levels ranged from undetectable in PMs (MRS > 20) to 2.6 +/- 2.7 pmol/mg microsomal protein in IMs (1.2 < MRS< 20), 7.6 +/- 4.7 in EMs (0.2 < MRS < 1.2) and 23.8 +/- 7.7 in UMs (MRS < 0.2), respectively. Analysis with respect to genotype demonstrated gradually increased expression and function for individuals with no, one, two or three functional gene copies per genome. The recently discovered -1584 C/G promoter polymorphism was identified as another major factor for expression and function with the mutant [-1584G] promoter type being consistently associated with significantly higher expression than [-1584C]. To investigate functional differences between the detected variant protein forms CYP2D6.1, 2D6.2, 2D6.9 and 2D6.10, we expressed them recombinantly in insect cells. The most significant difference was a decrease in the relative P450 holoprotein content of all allelic forms, including the common functional variant 2D6.2, in comparison to 2D6.1, whereas only modest Km changes were observed. Taken together, these data provide further insight into the complex mechanisms that govern the highly variable expression and function of CYP2D6.
细胞色素P4502D6(CYP2D6)的可变表达和功能导致了不同的表型,即超快代谢型(UM)、广泛代谢型(EM)、中间代谢型(IM)和慢代谢型(PM)。已知PM表型是由两个无效等位基因导致功能性CYP2D6蛋白缺失引起的,而具有功能等位基因的个体之间的巨大变异性在很大程度上仍无法解释。在本研究中,我们系统地研究了76份来自已知司巴丁代谢率(MRS)个体的肝活检样本,以探讨CYP2D6基因型、微粒体蛋白表达、布非洛尔1'-羟化酶活性与体内表型之间的关系。平均CYP2D6蛋白水平在PMs(MRS>20)中不可检测,在IMs(1.2<MRS<20)中为2.6±2.7 pmol/mg微粒体蛋白,在EMs(0.2<MRS<1.2)中为7.6±4.7,在UMs(MRS<0.2)中为23.8±7.7。关于基因型的分析表明,每个基因组中无、一、二或三个功能基因拷贝的个体的表达和功能逐渐增加。最近发现的-1584 C/G启动子多态性被确定为表达和功能的另一个主要因素,突变型[-1584G]启动子类型始终与明显高于[-1584C]的表达相关。为了研究检测到的变异蛋白形式CYP2D6.1、2D6.2、2D6.9和2D6.10之间的功能差异,我们在昆虫细胞中进行了重组表达。最显著的差异是,与2D6.1相比,所有等位基因形式(包括常见的功能变体2D6.2)的相对P450全蛋白含量均下降,而仅观察到适度的Km变化。综上所述,这些数据为控制CYP2D6高度可变表达和功能的复杂机制提供了进一步的见解。